A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
Study Identifier
M10-014
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
18 - 75 Years
Protocol Summary
The purpose of this study is to evaluate the safety and efficacy of a 6 mg twice a day dose of an investigational product in subjects with diabetic neuropathy
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 6614
Spring Valley, California, United States, 91978
Status
Not applicable
Location
Site Reference ID/Investigator# 6617
Walnut Creek, California, United States, 94598
Status
Not applicable
Location
Site Reference ID/Investigator# 6356
Hollywood, Florida, United States, 33021
Status
Not applicable
Location
Site Reference ID/Investigator# 6615
Tampa, Florida, United States, 33603
Status
Not applicable
Location
Site Reference ID/Investigator# 6358
Wellington, Florida, United States, 33414
Status
Not applicable
Location
Site Reference ID/Investigator# 6609
St Louis, Missouri, United States, 63141
Status
Not applicable
Showing {first} - {last} of {total} Results